Zacks Equity Research highlights recent performance and outlooks for major stocks, including Mastercard, Procter & Gamble, and Novartis. Mastercard has seen a 25.6% increase in shares, driven by acquisitions and digital solutions, though high operating expenses pose risks. Procter & Gamble outperformed its industry with a focus on sustainability, despite challenges in Greater China and currency volatility. Novartis faces concerns over patent losses and increased generic competition, impacting its stock performance.